Jonathan E. Rosenberg

机构：University of Maryland, Baltimore, Memorial Sloan Kettering Cancer Center, Cornell University · ORCID：0000-0003-2637-4249

发表论文 824 篇 · 总被引 46987 次 · h-index 85

代表论文

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer (2025 · Journal of Clinical Oncology · 被引 22)
Urothelial carcinoma: Perioperative considerations from top to bottom (2025 · CA A Cancer Journal for Clinicians · 被引 11)
Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma. (2025 · Journal of Clinical Oncology · 被引 5)
A phase 2 trial of androgen deprivation therapy interruption in patients responding exceptionally to androgen receptor pathway inhibitor in metastatic hormone-sensitive prostate cancer (A-DREAM / Alliance A032101). (2026 · Journal of Clinical Oncology · 被引 3)
Relationship Among DNA Damage Response Gene Alterations, Molecular Subtypes, and Survival Outcomes in Patients With Metastatic Bladder Cancer Treated on CALGB 90601 (2025 · JCO Precision Oncology · 被引 3)
RC48G001: A phase 2 study of disitamab vedotin in HER2-expressing previously treated advanced UC. (2026 · Journal of Clinical Oncology · 被引 2)